- Home
- PESI vs INBX Comparison
PESI vs INBX Comparison
Compare PESI & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PESI | INBX |
|---|---|---|
| Founded | 1990 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 243.9M | 999.7M |
| IPO Year | 1996 | 2024 |
Fundamental Metrics
Financial Performance| Metric | PESI | INBX |
|---|---|---|
| Price | $10.92 | $61.98 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 119.6K | ★ 135.2K |
| Earning Date | 05-07-2026 | 03-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $60,030,000.00 | $1,300,000.00 |
| Revenue This Year | $9.91 | $563.00 |
| Revenue Next Year | $62.48 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 550.00 |
| 52 Week Low | $6.25 | $10.81 |
| 52 Week High | $16.50 | $94.57 |
Technical Indicators
Market Signals| Indicator | PESI | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 29.80 | 34.24 |
| Support Level | $11.01 | $28.54 |
| Resistance Level | $12.37 | $85.97 |
| Average True Range (ATR) | 0.77 | 4.14 |
| MACD | -0.17 | -0.85 |
| Stochastic Oscillator | 30.84 | 11.65 |
Price Performance
Historical ComparisonAbout PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.